4.7 Article

Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia

Journal

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 42, Issue 7, Pages E203-E216

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.122.315499

Keywords

cholesterol; hypercholesterolemia; leucine repetition; lipoproteins; metabolism

Funding

  1. Basque Government [IT1264-19]
  2. Instituto de Salud Carlos III: CIBERCV
  3. FIS [PI19/0069]
  4. Fundacion Biofisica Bizkaia
  5. Programa de especializacion de Personal Investigador Doctor en la UPV/EHU (2019) 2019-2020
  6. PIF (2017-2018)
  7. PIF (2019-2020)
  8. Gobierno Vasco

Ask authors/readers for more resources

This study extensively characterized the activities of L8 and L11 variants located in the signal peptide through in vitro experiments. It was found that the L11 variant enhances intracellular degradation of LDLr, which may lead to inefficient LDLr transport and LDLr degradation, resulting in mild hypercholesterolemia.
Background: PCSK9 (Proprotein convertase subtilisin/kexin type 9) regulates LDL-C (low-density lipoprotein cholesterol) metabolism by targeting LDLr (LDL receptor) for lysosomal degradation. PCSK9 gain-of-function variants cause autosomal dominant hypercholesterolemia by reducing LDLr levels, the D374Y variant being the most severe, while loss-of-function variants are associated with low LDL-C levels. Gain-of-function and loss-of-function activities have also been attributed to variants occurring in the PCSK9 signal peptide. Among them, L11 is a very rare PCSK9 variant that seems to increase LDL-C values in a moderate way causing mild hypercholesterolemia. Methods: Using molecular biology and biophysics methodologies, activities of L8 and L11 variants, both located in the leucine repetition stretch of the signal peptide, have been extensively characterized in vitro. Results: L8 variant is not associated with increased LDLr activity, whereas L11 activity is increased by approximate to 20% compared with wt PCSK9. The results suggest that the L11 variant reduces LDLr levels intracellularly by a process resulting from impaired cleavage of the signal peptide. This would lead to less efficient LDLr transport to the cell membrane and promote LDLr intracellular degradation. Conclusions: Deletion of a leucine in the signal peptide in L8 variant does not affect PCSK9 activity, whereas the leucine duplication in the L11 variant enhances LDLr intracellular degradation. These findings highlight the importance of deep in vitro characterization of PCSK9 genetic variants to determine pathogenicity and improve clinical diagnosis and therapy of inherited familial hypercholesterolemia disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available